 | • レポートコード：MRC2-11QY08803 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、148ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は小児用ワクチンのグローバル市場について調査・分析したレポートです。種類別（ジフテリア、インフルエンザ、肝炎、肺炎球菌性疾患、髄膜炎菌性疾患、その他）市場規模、用途別（新生児、乳児、子供、思春期）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別小児用ワクチンの競争状況、市場シェア ・世界の小児用ワクチン市場：種類別市場規模 2015年-2020年（ジフテリア、インフルエンザ、肝炎、肺炎球菌性疾患、髄膜炎菌性疾患、その他） ・世界の小児用ワクチン市場：種類別市場規模予測 2021年-2026年（ジフテリア、インフルエンザ、肝炎、肺炎球菌性疾患、髄膜炎菌性疾患、その他） ・世界の小児用ワクチン市場：用途別市場規模 2015年-2020年（新生児、乳児、子供、思春期） ・世界の小児用ワクチン市場：用途別市場規模予測 2021年-2026年（新生児、乳児、子供、思春期） ・北米の小児用ワクチン市場分析：米国、カナダ ・ヨーロッパの小児用ワクチン市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの小児用ワクチン市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の小児用ワクチン市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの小児用ワクチン市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：GlaxoSmithKline、Merck、Pfizer、Sanofi、AstraZeneca、Novartis、Takeda Pharmaceutical、Bavarian Nordic、Baxter、LG Life Sciences、Lupin、S K Chemicals、Mitsubishi Tanabe Pharma、Janssen、Shenzhen Kangtai Biological Products、Sinovac Biotech、Bharat Biotech、Crucell、Dynavax、Serum Institute of India ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Pediatric Vaccines Market
The global Pediatric Vaccines market size is projected to reach US$ 30650 million by 2026, from US$ 28880 million in 2020, at a CAGR of 5.7%% during 2021-2026.
Global Pediatric Vaccines Scope and Market Size
Pediatric Vaccines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pediatric Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Pediatric Vaccines market is segmented into
Diphtheria
Influenza
Hepatitis
Pneumococcal Diseases
Meningococcal Diseases
Others
Segment by Application, the Pediatric Vaccines market is segmented into
Newborn
Infant
Child
Dolescent
Regional and Country-level Analysis
The Pediatric Vaccines market is analysed and market size information is provided by regions (countries).
The key regions covered in the Pediatric Vaccines market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Pediatric Vaccines Market Share Analysis
Pediatric Vaccines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Pediatric Vaccines business, the date to enter into the Pediatric Vaccines market, Pediatric Vaccines product introduction, recent developments, etc.
The major vendors covered:
GlaxoSmithKline
Merck
Pfizer
Sanofi
AstraZeneca
Novartis
Takeda Pharmaceutical
Bavarian Nordic
Baxter
LG Life Sciences
Lupin
S K Chemicals
Mitsubishi Tanabe Pharma
Janssen
Shenzhen Kangtai Biological Products
Sinovac Biotech
Bharat Biotech
Crucell
Dynavax
Serum Institute of India
1 Study Coverage
1.1 Pediatric Vaccines Product Introduction
1.2 Market Segments
1.3 Key Pediatric Vaccines Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Pediatric Vaccines Market Size Growth Rate by Type
1.4.2 Diphtheria
1.4.3 Influenza
1.4.4 Hepatitis
1.4.5 Pneumococcal Diseases
1.4.6 Meningococcal Diseases
1.4.7 Others
1.5 Market by Application
1.5.1 Global Pediatric Vaccines Market Size Growth Rate by Application
1.5.2 Newborn
1.5.3 Infant
1.5.4 Child
1.5.5 Dolescent
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Pediatric Vaccines Market Size, Estimates and Forecasts
2.1.1 Global Pediatric Vaccines Revenue 2015-2026
2.1.2 Global Pediatric Vaccines Sales 2015-2026
2.2 Global Pediatric Vaccines, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Pediatric Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Pediatric Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Pediatric Vaccines Competitor Landscape by Players
3.1 Pediatric Vaccines Sales by Manufacturers
3.1.1 Pediatric Vaccines Sales by Manufacturers (2015-2020)
3.1.2 Pediatric Vaccines Sales Market Share by Manufacturers (2015-2020)
3.2 Pediatric Vaccines Revenue by Manufacturers
3.2.1 Pediatric Vaccines Revenue by Manufacturers (2015-2020)
3.2.2 Pediatric Vaccines Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Pediatric Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Pediatric Vaccines Revenue in 2019
3.2.5 Global Pediatric Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Pediatric Vaccines Price by Manufacturers
3.4 Pediatric Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Pediatric Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pediatric Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Pediatric Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Pediatric Vaccines Market Size by Type (2015-2020)
4.1.1 Global Pediatric Vaccines Sales by Type (2015-2020)
4.1.2 Global Pediatric Vaccines Revenue by Type (2015-2020)
4.1.3 Pediatric Vaccines Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Pediatric Vaccines Market Size Forecast by Type (2021-2026)
4.2.1 Global Pediatric Vaccines Sales Forecast by Type (2021-2026)
4.2.2 Global Pediatric Vaccines Revenue Forecast by Type (2021-2026)
4.2.3 Pediatric Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Pediatric Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Pediatric Vaccines Market Size by Application (2015-2020)
5.1.1 Global Pediatric Vaccines Sales by Application (2015-2020)
5.1.2 Global Pediatric Vaccines Revenue by Application (2015-2020)
5.1.3 Pediatric Vaccines Price by Application (2015-2020)
5.2 Pediatric Vaccines Market Size Forecast by Application (2021-2026)
5.2.1 Global Pediatric Vaccines Sales Forecast by Application (2021-2026)
5.2.2 Global Pediatric Vaccines Revenue Forecast by Application (2021-2026)
5.2.3 Global Pediatric Vaccines Price Forecast by Application (2021-2026)
6 North America
6.1 North America Pediatric Vaccines by Country
6.1.1 North America Pediatric Vaccines Sales by Country
6.1.2 North America Pediatric Vaccines Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Pediatric Vaccines Market Facts & Figures by Type
6.3 North America Pediatric Vaccines Market Facts & Figures by Application
7 Europe
7.1 Europe Pediatric Vaccines by Country
7.1.1 Europe Pediatric Vaccines Sales by Country
7.1.2 Europe Pediatric Vaccines Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Pediatric Vaccines Market Facts & Figures by Type
7.3 Europe Pediatric Vaccines Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Pediatric Vaccines by Region
8.1.1 Asia Pacific Pediatric Vaccines Sales by Region
8.1.2 Asia Pacific Pediatric Vaccines Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Pediatric Vaccines Market Facts & Figures by Type
8.3 Asia Pacific Pediatric Vaccines Market Facts & Figures by Application
9 Latin America
9.1 Latin America Pediatric Vaccines by Country
9.1.1 Latin America Pediatric Vaccines Sales by Country
9.1.2 Latin America Pediatric Vaccines Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Pediatric Vaccines Market Facts & Figures by Type
9.3 Central & South America Pediatric Vaccines Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Pediatric Vaccines by Country
10.1.1 Middle East and Africa Pediatric Vaccines Sales by Country
10.1.2 Middle East and Africa Pediatric Vaccines Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Pediatric Vaccines Market Facts & Figures by Type
10.3 Middle East and Africa Pediatric Vaccines Market Facts & Figures by Application
11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Description and Business Overview
11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GlaxoSmithKline Pediatric Vaccines Products Offered
11.1.5 GlaxoSmithKline Related Developments
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Description and Business Overview
11.2.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Merck Pediatric Vaccines Products Offered
11.2.5 Merck Related Developments
11.3 Pfizer
11.3.1 Pfizer Corporation Information
11.3.2 Pfizer Description and Business Overview
11.3.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Pfizer Pediatric Vaccines Products Offered
11.3.5 Pfizer Related Developments
11.4 Sanofi
11.4.1 Sanofi Corporation Information
11.4.2 Sanofi Description and Business Overview
11.4.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Sanofi Pediatric Vaccines Products Offered
11.4.5 Sanofi Related Developments
11.5 AstraZeneca
11.5.1 AstraZeneca Corporation Information
11.5.2 AstraZeneca Description and Business Overview
11.5.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.5.4 AstraZeneca Pediatric Vaccines Products Offered
11.5.5 AstraZeneca Related Developments
11.6 Novartis
11.6.1 Novartis Corporation Information
11.6.2 Novartis Description and Business Overview
11.6.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Novartis Pediatric Vaccines Products Offered
11.6.5 Novartis Related Developments
11.7 Takeda Pharmaceutical
11.7.1 Takeda Pharmaceutical Corporation Information
11.7.2 Takeda Pharmaceutical Description and Business Overview
11.7.3 Takeda Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Takeda Pharmaceutical Pediatric Vaccines Products Offered
11.7.5 Takeda Pharmaceutical Related Developments
11.8 Bavarian Nordic
11.8.1 Bavarian Nordic Corporation Information
11.8.2 Bavarian Nordic Description and Business Overview
11.8.3 Bavarian Nordic Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Bavarian Nordic Pediatric Vaccines Products Offered
11.8.5 Bavarian Nordic Related Developments
11.9 Baxter
11.9.1 Baxter Corporation Information
11.9.2 Baxter Description and Business Overview
11.9.3 Baxter Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Baxter Pediatric Vaccines Products Offered
11.9.5 Baxter Related Developments
11.10 LG Life Sciences
11.10.1 LG Life Sciences Corporation Information
11.10.2 LG Life Sciences Description and Business Overview
11.10.3 LG Life Sciences Sales, Revenue and Gross Margin (2015-2020)
11.10.4 LG Life Sciences Pediatric Vaccines Products Offered
11.10.5 LG Life Sciences Related Developments
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Description and Business Overview
11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GlaxoSmithKline Pediatric Vaccines Products Offered
11.1.5 GlaxoSmithKline Related Developments
11.12 S K Chemicals
11.12.1 S K Chemicals Corporation Information
11.12.2 S K Chemicals Description and Business Overview
11.12.3 S K Chemicals Sales, Revenue and Gross Margin (2015-2020)
11.12.4 S K Chemicals Products Offered
11.12.5 S K Chemicals Related Developments
11.13 Mitsubishi Tanabe Pharma
11.13.1 Mitsubishi Tanabe Pharma Corporation Information
11.13.2 Mitsubishi Tanabe Pharma Description and Business Overview
11.13.3 Mitsubishi Tanabe Pharma Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Mitsubishi Tanabe Pharma Products Offered
11.13.5 Mitsubishi Tanabe Pharma Related Developments
11.14 Janssen
11.14.1 Janssen Corporation Information
11.14.2 Janssen Description and Business Overview
11.14.3 Janssen Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Janssen Products Offered
11.14.5 Janssen Related Developments
11.15 Shenzhen Kangtai Biological Products
11.15.1 Shenzhen Kangtai Biological Products Corporation Information
11.15.2 Shenzhen Kangtai Biological Products Description and Business Overview
11.15.3 Shenzhen Kangtai Biological Products Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Shenzhen Kangtai Biological Products Products Offered
11.15.5 Shenzhen Kangtai Biological Products Related Developments
11.16 Sinovac Biotech
11.16.1 Sinovac Biotech Corporation Information
11.16.2 Sinovac Biotech Description and Business Overview
11.16.3 Sinovac Biotech Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Sinovac Biotech Products Offered
11.16.5 Sinovac Biotech Related Developments
11.17 Bharat Biotech
11.17.1 Bharat Biotech Corporation Information
11.17.2 Bharat Biotech Description and Business Overview
11.17.3 Bharat Biotech Sales, Revenue and Gross Margin (2015-2020)
11.17.4 Bharat Biotech Products Offered
11.17.5 Bharat Biotech Related Developments
11.18 Crucell
11.18.1 Crucell Corporation Information
11.18.2 Crucell Description and Business Overview
11.18.3 Crucell Sales, Revenue and Gross Margin (2015-2020)
11.18.4 Crucell Products Offered
11.18.5 Crucell Related Developments
11.19 Dynavax
11.19.1 Dynavax Corporation Information
11.19.2 Dynavax Description and Business Overview
11.19.3 Dynavax Sales, Revenue and Gross Margin (2015-2020)
11.19.4 Dynavax Products Offered
11.19.5 Dynavax Related Developments
11.20 Serum Institute of India
11.20.1 Serum Institute of India Corporation Information
11.20.2 Serum Institute of India Description and Business Overview
11.20.3 Serum Institute of India Sales, Revenue and Gross Margin (2015-2020)
11.20.4 Serum Institute of India Products Offered
11.20.5 Serum Institute of India Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Pediatric Vaccines Market Estimates and Projections by Region
12.1.1 Global Pediatric Vaccines Sales Forecast by Regions 2021-2026
12.1.2 Global Pediatric Vaccines Revenue Forecast by Regions 2021-2026
12.2 North America Pediatric Vaccines Market Size Forecast (2021-2026)
12.2.1 North America: Pediatric Vaccines Sales Forecast (2021-2026)
12.2.2 North America: Pediatric Vaccines Revenue Forecast (2021-2026)
12.2.3 North America: Pediatric Vaccines Market Size Forecast by Country (2021-2026)
12.3 Europe Pediatric Vaccines Market Size Forecast (2021-2026)
12.3.1 Europe: Pediatric Vaccines Sales Forecast (2021-2026)
12.3.2 Europe: Pediatric Vaccines Revenue Forecast (2021-2026)
12.3.3 Europe: Pediatric Vaccines Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Pediatric Vaccines Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Pediatric Vaccines Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Pediatric Vaccines Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Pediatric Vaccines Market Size Forecast by Region (2021-2026)
12.5 Latin America Pediatric Vaccines Market Size Forecast (2021-2026)
12.5.1 Latin America: Pediatric Vaccines Sales Forecast (2021-2026)
12.5.2 Latin America: Pediatric Vaccines Revenue Forecast (2021-2026)
12.5.3 Latin America: Pediatric Vaccines Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Pediatric Vaccines Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Pediatric Vaccines Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Pediatric Vaccines Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Pediatric Vaccines Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Pediatric Vaccines Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Pediatric Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Pediatric Vaccines Market Segments
Table 2. Ranking of Global Top Pediatric Vaccines Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Pediatric Vaccines Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Diphtheria
Table 5. Major Manufacturers of Influenza
Table 6. Major Manufacturers of Hepatitis
Table 7. Major Manufacturers of Pneumococcal Diseases
Table 8. Major Manufacturers of Meningococcal Diseases
Table 9. Major Manufacturers of Others
Table 10. Global Pediatric Vaccines Market Size Growth Rate by Application 2020-2026 (K Units)
Table 11. Global Pediatric Vaccines Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 12. Global Pediatric Vaccines Sales by Regions 2015-2020 (K Units)
Table 13. Global Pediatric Vaccines Sales Market Share by Regions (2015-2020)
Table 14. Global Pediatric Vaccines Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global Pediatric Vaccines Sales by Manufacturers (2015-2020) (K Units)
Table 16. Global Pediatric Vaccines Sales Share by Manufacturers (2015-2020)
Table 17. Global Pediatric Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Pediatric Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pediatric Vaccines as of 2019)
Table 19. Pediatric Vaccines Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Pediatric Vaccines Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Pediatric Vaccines Price (2015-2020) (USD/Unit)
Table 22. Pediatric Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Pediatric Vaccines Product Type
Table 24. Date of International Manufacturers Enter into Pediatric Vaccines Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Pediatric Vaccines Sales by Type (2015-2020) (K Units)
Table 27. Global Pediatric Vaccines Sales Share by Type (2015-2020)
Table 28. Global Pediatric Vaccines Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Pediatric Vaccines Revenue Share by Type (2015-2020)
Table 30. Pediatric Vaccines Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 31. Global Pediatric Vaccines Sales by Application (2015-2020) (K Units)
Table 32. Global Pediatric Vaccines Sales Share by Application (2015-2020)
Table 33. North America Pediatric Vaccines Sales by Country (2015-2020) (K Units)
Table 34. North America Pediatric Vaccines Sales Market Share by Country (2015-2020)
Table 35. North America Pediatric Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 36. North America Pediatric Vaccines Revenue Market Share by Country (2015-2020)
Table 37. North America Pediatric Vaccines Sales by Type (2015-2020) (K Units)
Table 38. North America Pediatric Vaccines Sales Market Share by Type (2015-2020)
Table 39. North America Pediatric Vaccines Sales by Application (2015-2020) (K Units)
Table 40. North America Pediatric Vaccines Sales Market Share by Application (2015-2020)
Table 41. Europe Pediatric Vaccines Sales by Country (2015-2020) (K Units)
Table 42. Europe Pediatric Vaccines Sales Market Share by Country (2015-2020)
Table 43. Europe Pediatric Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 44. Europe Pediatric Vaccines Revenue Market Share by Country (2015-2020)
Table 45. Europe Pediatric Vaccines Sales by Type (2015-2020) (K Units)
Table 46. Europe Pediatric Vaccines Sales Market Share by Type (2015-2020)
Table 47. Europe Pediatric Vaccines Sales by Application (2015-2020) (K Units)
Table 48. Europe Pediatric Vaccines Sales Market Share by Application (2015-2020)
Table 49. Asia Pacific Pediatric Vaccines Sales by Region (2015-2020) (K Units)
Table 50. Asia Pacific Pediatric Vaccines Sales Market Share by Region (2015-2020)
Table 51. Asia Pacific Pediatric Vaccines Revenue by Region (2015-2020) (US$ Million)
Table 52. Asia Pacific Pediatric Vaccines Revenue Market Share by Region (2015-2020)
Table 53. Asia Pacific Pediatric Vaccines Sales by Type (2015-2020) (K Units)
Table 54. Asia Pacific Pediatric Vaccines Sales Market Share by Type (2015-2020)
Table 55. Asia Pacific Pediatric Vaccines Sales by Application (2015-2020) (K Units)
Table 56. Asia Pacific Pediatric Vaccines Sales Market Share by Application (2015-2020)
Table 57. Latin America Pediatric Vaccines Sales by Country (2015-2020) (K Units)
Table 58. Latin America Pediatric Vaccines Sales Market Share by Country (2015-2020)
Table 59. Latin Americaa Pediatric Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 60. Latin America Pediatric Vaccines Revenue Market Share by Country (2015-2020)
Table 61. Latin America Pediatric Vaccines Sales by Type (2015-2020) (K Units)
Table 62. Latin America Pediatric Vaccines Sales Market Share by Type (2015-2020)
Table 63. Latin America Pediatric Vaccines Sales by Application (2015-2020) (K Units)
Table 64. Latin America Pediatric Vaccines Sales Market Share by Application (2015-2020)
Table 65. Middle East and Africa Pediatric Vaccines Sales by Country (2015-2020) (K Units)
Table 66. Middle East and Africa Pediatric Vaccines Sales Market Share by Country (2015-2020)
Table 67. Middle East and Africa Pediatric Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 68. Middle East and Africa Pediatric Vaccines Revenue Market Share by Country (2015-2020)
Table 69. Middle East and Africa Pediatric Vaccines Sales by Type (2015-2020) (K Units)
Table 70. Middle East and Africa Pediatric Vaccines Sales Market Share by Type (2015-2020)
Table 71. Middle East and Africa Pediatric Vaccines Sales by Application (2015-2020) (K Units)
Table 72. Middle East and Africa Pediatric Vaccines Sales Market Share by Application (2015-2020)
Table 73. GlaxoSmithKline Corporation Information
Table 74. GlaxoSmithKline Description and Major Businesses
Table 75. GlaxoSmithKline Pediatric Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 76. GlaxoSmithKline Product
Table 77. GlaxoSmithKline Recent Development
Table 78. Merck Corporation Information
Table 79. Merck Description and Major Businesses
Table 80. Merck Pediatric Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. Merck Product
Table 82. Merck Recent Development
Table 83. Pfizer Corporation Information
Table 84. Pfizer Description and Major Businesses
Table 85. Pfizer Pediatric Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 86. Pfizer Product
Table 87. Pfizer Recent Development
Table 88. Sanofi Corporation Information
Table 89. Sanofi Description and Major Businesses
Table 90. Sanofi Pediatric Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 91. Sanofi Product
Table 92. Sanofi Recent Development
Table 93. AstraZeneca Corporation Information
Table 94. AstraZeneca Description and Major Businesses
Table 95. AstraZeneca Pediatric Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 96. AstraZeneca Product
Table 97. AstraZeneca Recent Development
Table 98. Novartis Corporation Information
Table 99. Novartis Description and Major Businesses
Table 100. Novartis Pediatric Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 101. Novartis Product
Table 102. Novartis Recent Development
Table 103. Takeda Pharmaceutical Corporation Information
Table 104. Takeda Pharmaceutical Description and Major Businesses
Table 105. Takeda Pharmaceutical Pediatric Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 106. Takeda Pharmaceutical Product
Table 107. Takeda Pharmaceutical Recent Development
Table 108. Bavarian Nordic Corporation Information
Table 109. Bavarian Nordic Description and Major Businesses
Table 110. Bavarian Nordic Pediatric Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 111. Bavarian Nordic Product
Table 112. Bavarian Nordic Recent Development
Table 113. Baxter Corporation Information
Table 114. Baxter Description and Major Businesses
Table 115. Baxter Pediatric Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 116. Baxter Product
Table 117. Baxter Recent Development
Table 118. LG Life Sciences Corporation Information
Table 119. LG Life Sciences Description and Major Businesses
Table 120. LG Life Sciences Pediatric Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 121. LG Life Sciences Product
Table 122. LG Life Sciences Recent Development
Table 123. Lupin Corporation Information
Table 124. Lupin Description and Major Businesses
Table 125. Lupin Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 126. Lupin Product
Table 127. Lupin Recent Development
Table 128. S K Chemicals Corporation Information
Table 129. S K Chemicals Description and Major Businesses
Table 130. S K Chemicals Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 131. S K Chemicals Product
Table 132. S K Chemicals Recent Development
Table 133. Mitsubishi Tanabe Pharma Corporation Information
Table 134. Mitsubishi Tanabe Pharma Description and Major Businesses
Table 135. Mitsubishi Tanabe Pharma Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 136. Mitsubishi Tanabe Pharma Product
Table 137. Mitsubishi Tanabe Pharma Recent Development
Table 138. Janssen Corporation Information
Table 139. Janssen Description and Major Businesses
Table 140. Janssen Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 141. Janssen Product
Table 142. Janssen Recent Development
Table 143. Shenzhen Kangtai Biological Products Corporation Information
Table 144. Shenzhen Kangtai Biological Products Description and Major Businesses
Table 145. Shenzhen Kangtai Biological Products Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 146. Shenzhen Kangtai Biological Products Product
Table 147. Shenzhen Kangtai Biological Products Recent Development
Table 148. Sinovac Biotech Corporation Information
Table 149. Sinovac Biotech Description and Major Businesses
Table 150. Sinovac Biotech Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 151. Sinovac Biotech Product
Table 152. Sinovac Biotech Recent Development
Table 153. Bharat Biotech Corporation Information
Table 154. Bharat Biotech Description and Major Businesses
Table 155. Bharat Biotech Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 156. Bharat Biotech Product
Table 157. Bharat Biotech Recent Development
Table 158. Crucell Corporation Information
Table 159. Crucell Description and Major Businesses
Table 160. Crucell Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 161. Crucell Product
Table 162. Crucell Recent Development
Table 163. Dynavax Corporation Information
Table 164. Dynavax Description and Major Businesses
Table 165. Dynavax Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 166. Dynavax Product
Table 167. Dynavax Recent Development
Table 168. Serum Institute of India Corporation Information
Table 169. Serum Institute of India Description and Major Businesses
Table 170. Serum Institute of India Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 171. Serum Institute of India Product
Table 172. Serum Institute of India Recent Development
Table 173. Global Pediatric Vaccines Sales Forecast by Regions (2021-2026) (K Units)
Table 174. Global Pediatric Vaccines Sales Market Share Forecast by Regions (2021-2026)
Table 175. Global Pediatric Vaccines Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 176. Global Pediatric Vaccines Revenue Market Share Forecast by Regions (2021-2026)
Table 177. North America: Pediatric Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 178. North America: Pediatric Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 179. Europe: Pediatric Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 180. Europe: Pediatric Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 181. Asia Pacific: Pediatric Vaccines Sales Forecast by Region (2021-2026) (K Units)
Table 182. Asia Pacific: Pediatric Vaccines Revenue Forecast by Region (2021-2026) (US$ Million)
Table 183. Latin America: Pediatric Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 184. Latin America: Pediatric Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 185. Middle East and Africa: Pediatric Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 186. Middle East and Africa: Pediatric Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 187. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 188. Key Challenges
Table 189. Market Risks
Table 190. Main Points Interviewed from Key Pediatric Vaccines Players
Table 191. Pediatric Vaccines Customers List
Table 192. Pediatric Vaccines Distributors List
Table 193. Research Programs/Design for This Report
Table 194. Key Data Information from Secondary Sources
Table 195. Key Data Information from Primary Sources
List of Figures
Figure 1. Pediatric Vaccines Product Picture
Figure 2. Global Pediatric Vaccines Sales Market Share by Type in 2020 & 2026
Figure 3. Diphtheria Product Picture
Figure 4. Influenza Product Picture
Figure 5. Hepatitis Product Picture
Figure 6. Pneumococcal Diseases Product Picture
Figure 7. Meningococcal Diseases Product Picture
Figure 8. Others Product Picture
Figure 9. Global Pediatric Vaccines Sales Market Share by Application in 2020 & 2026
Figure 10. Newborn
Figure 11. Infant
Figure 12. Child
Figure 13. Dolescent
Figure 14. Pediatric Vaccines Report Years Considered
Figure 15. Global Pediatric Vaccines Market Size 2015-2026 (US$ Million)
Figure 16. Global Pediatric Vaccines Sales 2015-2026 (K Units)
Figure 17. Global Pediatric Vaccines Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Pediatric Vaccines Sales Market Share by Region (2015-2020)
Figure 19. Global Pediatric Vaccines Sales Market Share by Region in 2019
Figure 20. Global Pediatric Vaccines Revenue Market Share by Region (2015-2020)
Figure 21. Global Pediatric Vaccines Revenue Market Share by Region in 2019
Figure 22. Global Pediatric Vaccines Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Pediatric Vaccines Revenue in 2019
Figure 24. Pediatric Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Pediatric Vaccines Sales Market Share by Type (2015-2020)
Figure 26. Global Pediatric Vaccines Sales Market Share by Type in 2019
Figure 27. Global Pediatric Vaccines Revenue Market Share by Type (2015-2020)
Figure 28. Global Pediatric Vaccines Revenue Market Share by Type in 2019
Figure 29. Global Pediatric Vaccines Market Share by Price Range (2015-2020)
Figure 30. Global Pediatric Vaccines Sales Market Share by Application (2015-2020)
Figure 31. Global Pediatric Vaccines Sales Market Share by Application in 2019
Figure 32. Global Pediatric Vaccines Revenue Market Share by Application (2015-2020)
Figure 33. Global Pediatric Vaccines Revenue Market Share by Application in 2019
Figure 34. North America Pediatric Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 35. North America Pediatric Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 36. North America Pediatric Vaccines Sales Market Share by Country in 2019
Figure 37. North America Pediatric Vaccines Revenue Market Share by Country in 2019
Figure 38. U.S. Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 39. U.S. Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Canada Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 41. Canada Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. North America Pediatric Vaccines Market Share by Type in 2019
Figure 43. North America Pediatric Vaccines Market Share by Application in 2019
Figure 44. Europe Pediatric Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 45. Europe Pediatric Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe Pediatric Vaccines Sales Market Share by Country in 2019
Figure 47. Europe Pediatric Vaccines Revenue Market Share by Country in 2019
Figure 48. Germany Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 49. Germany Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 51. France Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 53. U.K. Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 55. Italy Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 57. Russia Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Europe Pediatric Vaccines Market Share by Type in 2019
Figure 59. Europe Pediatric Vaccines Market Share by Application in 2019
Figure 60. Asia Pacific Pediatric Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 61. Asia Pacific Pediatric Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific Pediatric Vaccines Sales Market Share by Region in 2019
Figure 63. Asia Pacific Pediatric Vaccines Revenue Market Share by Region in 2019
Figure 64. China Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 65. China Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 67. Japan Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 69. South Korea Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 71. India Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 73. Australia Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 75. Taiwan Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 77. Indonesia Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 79. Thailand Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 81. Malaysia Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 83. Philippines Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 85. Vietnam Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Asia Pacific Pediatric Vaccines Market Share by Type in 2019
Figure 87. Asia Pacific Pediatric Vaccines Market Share by Application in 2019
Figure 88. Latin America Pediatric Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 89. Latin America Pediatric Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 90. Latin America Pediatric Vaccines Sales Market Share by Country in 2019
Figure 91. Latin America Pediatric Vaccines Revenue Market Share by Country in 2019
Figure 92. Mexico Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 93. Mexico Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Brazil Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 95. Brazil Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Argentina Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 97. Argentina Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Latin America Pediatric Vaccines Market Share by Type in 2019
Figure 99. Latin America Pediatric Vaccines Market Share by Application in 2019
Figure 100. Middle East and Africa Pediatric Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 101. Middle East and Africa Pediatric Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 102. Middle East and Africa Pediatric Vaccines Sales Market Share by Country in 2019
Figure 103. Middle East and Africa Pediatric Vaccines Revenue Market Share by Country in 2019
Figure 104. Turkey Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 105. Turkey Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Saudi Arabia Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 107. Saudi Arabia Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. U.A.E Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 109. U.A.E Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Middle East and Africa Pediatric Vaccines Market Share by Type in 2019
Figure 111. Middle East and Africa Pediatric Vaccines Market Share by Application in 2019
Figure 112. North America Pediatric Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. North America Pediatric Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Europe Pediatric Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Europe Pediatric Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Asia Pacific Pediatric Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. Asia Pacific Pediatric Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Latin America Pediatric Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 119. Latin America Pediatric Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Middle East and Africa Pediatric Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 121. Middle East and Africa Pediatric Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Porter's Five Forces Analysis
Figure 123. Channels of Distribution
Figure 124. Distributors Profiles
Figure 125. Bottom-up and Top-down Approaches for This Report
Figure 126. Data Triangulation
Figure 127. Key Executives Interviewed
小児用医薬品・ワクチンの世界市場（～2026年） Children differ from adults in many aspects of pharmacotherapy, including capabilities for drug administration, medicine-related toxicity, and taste preferences. It is essential that pediatric medicines are formulated to best suit a child's age, size, physiologic condition, and treatment requirement…- 予防的B型肝炎ウイルスワクチンの世界市場（～2026年） The main objective of hepatitis B immunization strategies is to prevent chronic hepatitis B virus infection and its serious consequences, including liver cirrhosis and hepatocellular cancer. The increasing prevalence and incidence of hepatitis B infection is the dominant factor of driving the growth…
- 小児放射線の世界市場（～2026年） Pediatric radiology is a subspecialty of radiology involving the imaging of fetuses, infants, children, adolescents and young adults. The key factor contributing to the pediatric radiology market is the increasing incidence of diagnosis. Market Analysis and Insights: Global Pediatric Radiology Marke…
- 髄膜炎菌ワクチンの世界市場（～2026年） Market Analysis and Insights: Global Meningococcal Vaccines Market The global Meningococcal Vaccines market size is projected to reach US$ 250.5 million by 2026, from US$ 239 million in 2020, at a CAGR of 4.4%% during 2021-2026. Global Meningococcal Vaccines Scope and Market Size Meningococcal Vacci…
- 小児神経芽細胞腫治療の世界市場（～2026年） In terms of therapy type, the market has been classified into immunotherapy, chemotherapy, and others. The chemotherapy segment held leading market share in 2017. Market Analysis and Insights: Global Pediatric Neuroblastoma Treatment Market The global Pediatric Neuroblastoma Treatment market size is…